Literature DB >> 23866032

Techniques of extracorporeal cytokine removal: a systematic review of human studies.

Rafidah Atan1, David C A Crosbie, Rinaldo Bellomo.   

Abstract

BACKGROUND AND AIMS: Hypercytokinemia is believed to be harmful and reducing cytokine levels is considered beneficial. Extracorporeal blood purification (EBP) techniques have been studied for the purpose of cytokine reduction. We aimed to study the efficacy of various EBP techniques for cytokine removal as defined by technical measures.
METHOD: We conducted a systematic search for human clinical trials which focused on technical measures of cytokine removal by EBP techniques. We identified 41 articles and analyzed cytokine removal according to clearance (CL), sieving coefficient (SC), ultrafiltrate (UF) concentration and percentage removed.
RESULTS: We identified the following techniques for cytokine removal: standard hemofiltration, high volume hemofiltration (HVHF), high cut-off (HCO) hemofiltration, plasma filtration techniques, and adsorption techniques, ultrafiltration (UF) techniques relating to cardiopulmonary bypass (CPB), extracorporeal liver support systems and hybrid techniques including combined plasma filtration adsorption. Standard filtration techniques and UF techniques during CPB were generally poor at removing cytokines (median CL for interleukin 6 [IL-6]: 1.09 mL/min, TNF-alpha 0.74 mL/min). High cut-off techniques consistently offered moderate cytokine removal (median CL for IL-6: 26.5 mL/min, interleukin 1 receptor antagonist [IL-1RA]: 40.2 mL/min). Plasma filtration and extracorporeal liver support appear promising but data are few. Only one paper studied combined plasma filtration and adsorption and found low rates of removal. The clinical significance of the cytokine removal achieved with more efficacious techniques is unknown.
CONCLUSION: Human clinical trials indicate that high cut-off hemofiltration techniques, and perhaps plasma filtration and extracorporeal liver support techniques are likely more efficient in removing cytokines than standard techniques.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23866032     DOI: 10.3109/0886022X.2013.815089

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

Review 1.  Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.

Authors:  Rinaldo Bellomo; Claudio Ronco; Ravindra L Mehta; Pierre Asfar; Julie Boisramé-Helms; Michael Darmon; Jean-Luc Diehl; Jacques Duranteau; Eric A J Hoste; Joannes-Boyau Olivier; Matthieu Legrand; Nicolas Lerolle; Manu L N G Malbrain; Johan Mårtensson; Heleen M Oudemans-van Straaten; Jean-Jacques Parienti; Didier Payen; Sophie Perinel; Esther Peters; Peter Pickkers; Eric Rondeau; Miet Schetz; Christophe Vinsonneau; Julia Wendon; Ling Zhang; Pierre-François Laterre
Journal:  Ann Intensive Care       Date:  2017-05-04       Impact factor: 6.925

Review 2.  Renal replacement therapy in acute kidney injury: controversy and consensus.

Authors:  Claudio Ronco; Zaccaria Ricci; Daniel De Backer; John A Kellum; Fabio S Taccone; Michael Joannidis; Peter Pickkers; Vincenzo Cantaluppi; Franco Turani; Patrick Saudan; Rinaldo Bellomo; Olivier Joannes-Boyau; Massimo Antonelli; Didier Payen; John R Prowle; Jean-Louis Vincent
Journal:  Crit Care       Date:  2015-04-06       Impact factor: 9.097

3.  The effects of early high-volume hemofiltration on prolonged cardiac arrest in rats with reperfusion by cardiopulmonary bypass: a randomized controlled animal study.

Authors:  Koichiro Shinozaki; Joshua W Lampe; Junhwan Kim; Tai Yin; Tong Da; Shigeto Oda; Hiroyuki Hirasawa; Lance B Becker
Journal:  Intensive Care Med Exp       Date:  2016-09-09

4.  Successful use of combined blood purification techniques in splenectomised patient with septic shock in streptococcus pneumoniae infection - a case report.

Authors:  Andreja Sinkovic; Barbara Kit; Andrej Markota
Journal:  BMC Infect Dis       Date:  2018-08-29       Impact factor: 3.090

Review 5.  Cytokine Storm in COVID-19: Immunopathogenesis and Therapy.

Authors:  Christian Zanza; Tatsiana Romenskaya; Alice Chiara Manetti; Francesco Franceschi; Raffaele La Russa; Giuseppe Bertozzi; Aniello Maiese; Gabriele Savioli; Gianpietro Volonnino; Yaroslava Longhitano
Journal:  Medicina (Kaunas)       Date:  2022-01-18       Impact factor: 2.430

6.  Low-dose polymyxin: an option for therapy of Gram-negative sepsis.

Authors:  Stephan Harm; Franz Gabor; Jens Hartmann
Journal:  Innate Immun       Date:  2016-03-17       Impact factor: 2.680

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.